Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000415479 | SCV000328382 | pathogenic | Pfeiffer syndrome | 2016-09-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000558628 | SCV000659624 | pathogenic | FGFR2-related craniosynostosis | 2023-01-11 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 7 of the FGFR2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in FGFR2 cause disease. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Pfeiffer syndrome (PMID: 7795583, 16418739, 25271085, 270283566). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 374814). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001559997 | SCV001782326 | pathogenic | not provided | 2024-04-08 | criteria provided, single submitter | clinical testing | Canonical splice site variant in a gene for which loss-of-function is not a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 11781872, 16010693, 11325814, 11173845, 10394936, 27028366, 10731087, 34358384, 7795583, 33502061, 36292735, 24127277, 16418739, 25271085) |
Genomic Medicine Center of Excellence, |
RCV000415479 | SCV004807327 | uncertain significance | Pfeiffer syndrome | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796173 | SCV005418479 | pathogenic | Acrocephalosyndactyly type I; Beare-Stevenson cutis gyrata syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis; Crouzon syndrome; Saethre-Chotzen syndrome; Familial scaphocephaly syndrome, McGillivray type; Bent bone dysplasia syndrome 1; Gastric cancer; LADD syndrome 1 | criteria provided, single submitter | clinical testing | PVS1+PM2_Supporting+PS4+PM6 | |
Clinical Genetics Laboratory, |
RCV000415479 | SCV000996314 | pathogenic | Pfeiffer syndrome | 2014-03-14 | no assertion criteria provided | research |